Treatment of Acute Urticaria
For acute urticaria, second-generation non-sedating H1 antihistamines are the first-line treatment, with dose escalation up to 4 times the standard dose for inadequate response. 1, 2
First-Line Treatment
Non-sedating second-generation H1 antihistamines are the mainstay of therapy for acute urticaria, with options including:
Patients should be offered at least two different non-sedating antihistamines, as responses and tolerance vary between individuals 2
For mild cases (hives covering <10% body surface area), continue with standard dose of oral antihistamines 1
Second-Line Treatment
For moderate cases (10-30% body surface area) or inadequate response to standard dose, increase the antihistamine dose up to 4 times the standard dose when benefits outweigh risks 1, 2
First-generation antihistamines should generally be avoided due to sedation and anticholinergic effects 3
Cooling antipruritic lotions (calamine or 1% menthol in aqueous cream) can provide symptomatic relief 4, 2
Third-Line Treatment
For severe cases (>30% body surface area) or inadequate response to increased antihistamine dosing, systemic corticosteroids (prednisone 0.5-1 mg/kg/day) are recommended until hives resolve to grade 1 1
However, recent evidence suggests that the addition of corticosteroids to antihistamines may not provide additional benefit in some cases of acute urticaria 5
Consider same-day dermatology consultation for severe cases 1
Special Considerations
Assess for airway compromise in cases with angioedema 1
Consider epinephrine for severe symptoms affecting breathing in cases with angioedema, as it alleviates pruritus, urticaria, and angioedema through its action on alpha and beta-adrenergic receptors 1, 6
Identify and minimize aggravating factors such as:
NSAIDs should be avoided in aspirin-sensitive patients with urticaria 4, 2
ACE inhibitors should be avoided in patients with angioedema without weals 4, 2
Treatment Algorithm Based on Severity
Mild Acute Urticaria (<10% BSA)
Moderate Acute Urticaria (10-30% BSA) or Inadequate Response
Severe Acute Urticaria (>30% BSA) or Inadequate Response
Acute Urticaria with Angioedema and Respiratory Compromise
Common Pitfalls and Caveats
Avoid first-generation antihistamines due to sedation and potential to convert minor reactions into hemodynamically significant events 3
The course of acute urticaria is typically self-limited, with most cases resolving within 3 weeks 7
While combination therapy with H1 and H2 antihistamines has been suggested for some refractory cases, evidence does not justify routine addition of H2-antihistamines to H1-antihistamine treatment 8
For patients with renal impairment, avoid acrivastine in moderate renal impairment, and halve the dose of cetirizine, levocetirizine, and hydroxyzine 2
For patients with hepatic impairment, avoid mizolastine in significant hepatic impairment 2